GO:0044828 host-mediated suppression of viral genome replication

Host-mediated suppression of viral genome replication (GO:0044828) is a biological process in which a host organism interferes with, inhibits or disrupts viral genome replication. This process is a cornerstone of intrinsic and innate antiviral immunity, acting alongside interferon signaling and adaptive immunity to limit viral amplification and spread. Understanding GO:0044828 is essential for researchers studying virus-host interactions, because it defines the cellular strategies that viruses must overcome to establish productive infection. The term is particularly relevant to DNA viruses such as hepatitis B virus (HBV) and adenovirus, where host factors can directly target viral genome replication intermediates or the viral replication machinery. In HBV, for example, host-mediated suppression can occur through interferon-stimulated genes and cellular DNA damage response pathways that restrict viral covalently closed circular DNA (cccDNA) transcription and genome replication. In adenovirus, host DNA damage response (DDR) factors can be activated or delayed by viral infection, and these host responses can suppress viral genome replication. Consequently, GO:0044828 serves as a conceptual framework for identifying and characterizing host restriction factors, understanding viral immune evasion, and developing host-directed antiviral therapies.

GO:0044828, host-mediated suppression of viral genome replication, is defined as a process in which a host organism interferes with, inhibits or disrupts viral genome replication. It is a biological_process term with the synonym negative regulation by host of viral genome replication. This term captures any host-driven mechanism that negatively regulates the replication of a viral genome, including direct targeting of viral nucleic acids, inhibition of viral replication proteins, or activation of cellular pathways that create an unfavorable environment for viral genome synthesis.

GO:0044828 is important because it defines the host's ability to directly limit viral genome replication, a key determinant of viral load, disease progression, and transmission. By understanding which host factors suppress viral genome replication, researchers can identify new antiviral targets, predict viral pathogenesis, and develop host-directed therapies that are less prone to viral resistance.

The following host genes and proteins have been implicated in host-mediated suppression of viral genome replication, based on studies of HBV and adenovirus model systems.

Host-mediated suppression of viral genome replication is regulated by interferon signaling, DNA damage response pathways, and cellular stress responses. Type I interferons (IFN-alpha/beta) bind to their receptors and activate the JAK-STAT pathway, leading to expression of ISGs that directly inhibit viral genome replication. In adenovirus infection, the host DNA damage response, including ATM and ATR kinases, is modulated by viral proteins, and this regulation can determine the efficiency of viral genome replication. Additionally, viral proteins can counteract host suppression by degrading or inhibiting restriction factors, as seen in HBV and adenovirus.

Host-mediated suppression of HBV genome replication is critical for controlling chronic hepatitis B. In HBV model systems such as SNU cell lines, host factors that suppress cccDNA replication and viral genome synthesis are studied to understand viral persistence and to develop therapies. Impaired host suppression can lead to high viral loads, liver inflammation, and progression to cirrhosis and hepatocellular carcinoma.

Adenovirus infections are influenced by host-mediated suppression of viral genome replication. The host DNA damage response can restrict adenovirus replication, and viral proteins can delay or counteract this response. Understanding these interactions is important for developing antiviral strategies against adenovirus, especially in immunocompromised patients.

Many viruses, including HBV and adenovirus, have evolved mechanisms to evade host-mediated suppression of viral genome replication. For example, adenovirus can delay the host DNA damage response to promote its own replication. HBV can interfere with interferon signaling to reduce ISG-mediated suppression. Studying these evasion mechanisms can reveal new targets for antiviral therapy.

Genome-wide CRISPR knockout screens can identify host genes that suppress viral genome replication. In HBV and adenovirus models, knocking out candidate genes followed by viral replication assays reveals whether the gene restricts or promotes viral replication.

RNA-seq measures changes in host gene expression, including ISGs and DDR genes, during viral infection. This helps identify host pathways that are activated to suppress viral genome replication.

Proteomic approaches can identify host proteins that interact with viral replication proteins or viral genomes, revealing direct suppression mechanisms.

Quantitative PCR, Southern blot, and luciferase-based replicon assays measure viral genome replication levels in the presence or absence of specific host factors.

Researchers studying host-mediated suppression of viral genome replication-related genes often need to determine whether a candidate gene is causally involved in restricting viral replication or is merely a bystander. EDITGENE provides comprehensive CRISPR-based cell model services to enable such causal studies in HBV, adenovirus, and other viral infection models.

GO:0044828, host-mediated suppression of viral genome replication, is a fundamental biological process that defines how host cells restrict viral genome replication. Studies in HBV and adenovirus models have revealed key host factors, including interferon-stimulated genes and DNA damage response proteins, that suppress viral replication. Understanding this process is essential for developing host-directed antivirals and for predicting viral pathogenesis. EDITGENE provides comprehensive CRISPR cell model services to accelerate research on host-mediated suppression of viral genome replication.